Transneural Therapeutics, Inc.
PrivateLast Round
Seed
Apr 22, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Transneural Therapeutics, Inc. is a biotechnology company that develops novel neuroplastogens to treat neuropsychiatric and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transneural Therapeutics, Inc. Comparables
Compare Transneural Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 88% | |
| Psilera | 85% | |
| Diamond Therapeutics | 85% |
Transneural Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 22, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 109% MoM.
Transneural Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Transneural Therapeutics, Inc.'s valuation, stock price, and market status.
Is Transneural Therapeutics, Inc. a public or private company?
Transneural Therapeutics, Inc. is a private company.
What is the current stock price of Transneural Therapeutics, Inc.?
Transneural Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Transneural Therapeutics, Inc. worth (valuation)?
Valuation information for Transneural Therapeutics, Inc. is not publicly available.
Can I buy Transneural Therapeutics, Inc. stock?
Transneural Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Transneural Therapeutics, Inc.'s last funding round?
Transneural Therapeutics, Inc.'s most recent funding round was Seed on April 22, 2025.
Who are the main investors in Transneural Therapeutics, Inc.?
Investor information for Transneural Therapeutics, Inc. is not publicly disclosed.
Will Transneural Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Transneural Therapeutics, Inc..
How can I track Transneural Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Transneural Therapeutics, Inc.'s secondary market activity and sign up for updates.